Israel Launches Anti-Dumping Probe Into Canadian Cannabis Imports

Israeli trade authorities have initiated an anti-dumping investigation into Canadian medical cannabis imports, examining whether products are being sold below fair market value in violation of international trade rules. The probe targets multiple Canadian licensed producers who have established significant market share in Israel's medical cannabis program over the past three years.

The investigation centers on pricing practices that Israeli domestic producers claim undercut local cultivation operations. Canadian companies including Canopy Growth, Tilray, and Aurora Cannabis have exported millions of dollars worth of medical cannabis to Israel since 2019, when the country opened its market to international suppliers. Israeli officials will examine whether these imports are priced below production costs or domestic Canadian market rates.

Israel represents a critical export market for Canadian cannabis companies seeking international revenue streams as domestic demand remains constrained. The country's medical cannabis program serves over 100,000 patients, with imports accounting for roughly 40% of total supply. Canadian producers have leveraged lower production costs and established cultivation infrastructure to compete aggressively on price against Israeli greenhouse operations.

Anti-dumping measures could include tariffs or import restrictions that would significantly impact Canadian exporters' profitability in the Israeli market. Similar trade disputes in other agricultural sectors have resulted in duties ranging from 15% to 50%, which would eliminate most pricing advantages Canadian producers currently hold. The investigation timeline typically spans 12-18 months before final determinations.

The probe reflects broader tensions in global cannabis trade as countries balance supporting domestic industries against providing patients with affordable medical cannabis access. Canadian companies have faced similar challenges in European markets, where local producers increasingly lobby for protection against low-cost imports. The outcome will likely influence how other importing countries approach trade policy as international cannabis commerce expands.